The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

Research output: Contribution to journalArticle

Standard

The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. / Trovik, Clement; Bauer, Henrik C F; Styring, Emelie; Sundby Hall, Kirsten; Vult Von Steyern, Fredrik; Eriksson, Sigvard; Johansson, Ingela; Sampo, Mika; Laitinen, Minna; Kalén, Anders; Jónsson, Halldór; Jebsen, Nina L; Eriksson, Mikael; Tukiainen, Erkki; Wall, Najme; Zaikova, Olga; Sigurðsson, Helgi; Lehtinen, Tuula; Bjerkehagen, Bodil; Skorpil, Mikael; Egil Eide, Geir; Johansson, Elisabeth; Alvegard, Thor A.

In: Acta Orthopaedica, Vol. 88, No. 3, 07.03.2017, p. 341-347.

Research output: Contribution to journalArticle

Harvard

Trovik, C, Bauer, HCF, Styring, E, Sundby Hall, K, Vult Von Steyern, F, Eriksson, S, Johansson, I, Sampo, M, Laitinen, M, Kalén, A, Jónsson, H, Jebsen, NL, Eriksson, M, Tukiainen, E, Wall, N, Zaikova, O, Sigurðsson, H, Lehtinen, T, Bjerkehagen, B, Skorpil, M, Egil Eide, G, Johansson, E & Alvegard, TA 2017, 'The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma', Acta Orthopaedica, vol. 88, no. 3, pp. 341-347. https://doi.org/10.1080/17453674.2017.1293441

APA

Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., Johansson, I., Sampo, M., Laitinen, M., Kalén, A., Jónsson, H., Jebsen, N. L., Eriksson, M., Tukiainen, E., Wall, N., Zaikova, O., Sigurðsson, H., Lehtinen, T., Bjerkehagen, B., ... Alvegard, T. A. (2017). The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta Orthopaedica, 88(3), 341-347. https://doi.org/10.1080/17453674.2017.1293441

CBE

Trovik C, Bauer HCF, Styring E, Sundby Hall K, Vult Von Steyern F, Eriksson S, Johansson I, Sampo M, Laitinen M, Kalén A, Jónsson H, Jebsen NL, Eriksson M, Tukiainen E, Wall N, Zaikova O, Sigurðsson H, Lehtinen T, Bjerkehagen B, Skorpil M, Egil Eide G, Johansson E, Alvegard TA. 2017. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta Orthopaedica. 88(3):341-347. https://doi.org/10.1080/17453674.2017.1293441

MLA

Vancouver

Author

Trovik, Clement ; Bauer, Henrik C F ; Styring, Emelie ; Sundby Hall, Kirsten ; Vult Von Steyern, Fredrik ; Eriksson, Sigvard ; Johansson, Ingela ; Sampo, Mika ; Laitinen, Minna ; Kalén, Anders ; Jónsson, Halldór ; Jebsen, Nina L ; Eriksson, Mikael ; Tukiainen, Erkki ; Wall, Najme ; Zaikova, Olga ; Sigurðsson, Helgi ; Lehtinen, Tuula ; Bjerkehagen, Bodil ; Skorpil, Mikael ; Egil Eide, Geir ; Johansson, Elisabeth ; Alvegard, Thor A. / The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. In: Acta Orthopaedica. 2017 ; Vol. 88, No. 3. pp. 341-347.

RIS

TY - JOUR

T1 - The Scandinavian Sarcoma Group Central Register

T2 - 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

AU - Trovik, Clement

AU - Bauer, Henrik C F

AU - Styring, Emelie

AU - Sundby Hall, Kirsten

AU - Vult Von Steyern, Fredrik

AU - Eriksson, Sigvard

AU - Johansson, Ingela

AU - Sampo, Mika

AU - Laitinen, Minna

AU - Kalén, Anders

AU - Jónsson, Halldór

AU - Jebsen, Nina L

AU - Eriksson, Mikael

AU - Tukiainen, Erkki

AU - Wall, Najme

AU - Zaikova, Olga

AU - Sigurðsson, Helgi

AU - Lehtinen, Tuula

AU - Bjerkehagen, Bodil

AU - Skorpil, Mikael

AU - Egil Eide, Geir

AU - Johansson, Elisabeth

AU - Alvegard, Thor A.

PY - 2017/3/7

Y1 - 2017/3/7

N2 - Purpose — We wanted to examine the potential of the Scandinavian Sarcoma Group (SSG) Central Register, and evaluate referral and treatment practice for soft-tissue sarcomas in the extremities and trunk wall (STS) in the Nordic countries. Background — Based on incidence rates from the literature, 8,150 (7,000–9,300) cases of STS of the extremity and trunk wall should have been diagnosed in Norway, Finland, Iceland, and Sweden from 1987 through 2011. The SSG Register has 6,027 cases registered from this period, with 5,837 having complete registration of key variables. 10 centers have been reporting to the Register. The 5 centers that consistently report treat approximately 90% of the cases in their respective regions. The remaining centers have reported all the patients who were treated during certain time periods, but not for the entire 25-year period. Results — 59% of patients were referred to a sarcoma center untouched, i.e. before any attempt at open biopsy. There was an improvement from 52% during the first 5 years to 70% during the last 5 years. 50% had wide or better margins at surgery. Wide margins are now achieved less often than 20 years ago, in parallel with an increase in the use of radiotherapy. For the centers that consistently report, 97% of surviving patients are followed for more than 4 years. Metastasis-free survival (MFS) increased from 67% to 73% during the 25-year period. Interpretation — The Register is considered to be representative of extremity and trunk wall sarcoma disease in the population of Scandinavia, treated at the reporting centers. There were no clinically significant differences in treatment results at these centers.

AB - Purpose — We wanted to examine the potential of the Scandinavian Sarcoma Group (SSG) Central Register, and evaluate referral and treatment practice for soft-tissue sarcomas in the extremities and trunk wall (STS) in the Nordic countries. Background — Based on incidence rates from the literature, 8,150 (7,000–9,300) cases of STS of the extremity and trunk wall should have been diagnosed in Norway, Finland, Iceland, and Sweden from 1987 through 2011. The SSG Register has 6,027 cases registered from this period, with 5,837 having complete registration of key variables. 10 centers have been reporting to the Register. The 5 centers that consistently report treat approximately 90% of the cases in their respective regions. The remaining centers have reported all the patients who were treated during certain time periods, but not for the entire 25-year period. Results — 59% of patients were referred to a sarcoma center untouched, i.e. before any attempt at open biopsy. There was an improvement from 52% during the first 5 years to 70% during the last 5 years. 50% had wide or better margins at surgery. Wide margins are now achieved less often than 20 years ago, in parallel with an increase in the use of radiotherapy. For the centers that consistently report, 97% of surviving patients are followed for more than 4 years. Metastasis-free survival (MFS) increased from 67% to 73% during the 25-year period. Interpretation — The Register is considered to be representative of extremity and trunk wall sarcoma disease in the population of Scandinavia, treated at the reporting centers. There were no clinically significant differences in treatment results at these centers.

UR - http://www.scopus.com/inward/record.url?scp=85014579273&partnerID=8YFLogxK

U2 - 10.1080/17453674.2017.1293441

DO - 10.1080/17453674.2017.1293441

M3 - Article

C2 - 28266233

AN - SCOPUS:85014579273

VL - 88

SP - 341

EP - 347

JO - Acta Orthopaedica

JF - Acta Orthopaedica

SN - 1745-3682

IS - 3

ER -